These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 6428891)
1. Use of specific antibody for rapid clearance of circulating blood background from radiolabeled tumor imaging proteins. Goodwin D; Meares C; Diamanti C; McCall M; Lai C; Torti F; McTigue M; Martin B Eur J Nucl Med; 1984; 9(5):209-15. PubMed ID: 6428891 [TBL] [Abstract][Full Text] [Related]
2. Scintigraphic biodistribution and plasma kinetics of indium 111-labeled transferrin in dogs. Berry CR; Fisher P; Koblik PD; Guilford WG; Hornof WH Am J Vet Res; 1997 Nov; 58(11):1188-92. PubMed ID: 9361875 [TBL] [Abstract][Full Text] [Related]
3. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients. Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150 [TBL] [Abstract][Full Text] [Related]
4. Enhanced clearance of radiolabeled murine monoclonal antibody by a syngeneic anti-idiotype antibody in tumor-bearing nude mice. Sharkey RM; Boerman OC; Natale A; Pawlyk D; Monestier M; Losman MJ; Goldenberg DM Int J Cancer; 1992 May; 51(2):266-73. PubMed ID: 1568794 [TBL] [Abstract][Full Text] [Related]
5. Metabolizable 111In chelate conjugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in mice. Haseman MK; Goodwin DA; Meares CF; Kaminski MS; Wensel TG; McCall MJ; Levy R Eur J Nucl Med; 1986; 12(9):455-60. PubMed ID: 3102237 [TBL] [Abstract][Full Text] [Related]
6. Radioimmunodetection of gliomas by administration of radiolabelled monoclonal antibodies. Experimental data. Stavrou D; Mellert W; Bilzer T; Senekowitsch R; Keiditsch E; Mehraein P Anticancer Res; 1985; 5(2):147-56. PubMed ID: 3994308 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of indium-111 BLEDTA in man. Sartoris DJ; Goodwin DA; Meares CF; DeRiemer LH; Fajardo LF Invest Radiol; 1984; 19(3):221-7. PubMed ID: 6206021 [TBL] [Abstract][Full Text] [Related]
8. Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo. Pardridge WM; Buciak JL; Friden PM J Pharmacol Exp Ther; 1991 Oct; 259(1):66-70. PubMed ID: 1920136 [TBL] [Abstract][Full Text] [Related]
9. Rapid background reduction of circulating sodium iodide I 125-labelled Pisum sativum agglutinin used as a tumor-imaging radiopharmaceutical by the chemically galactosylated antibody. Kojima S; Kubota K; Kubodera A; Imagawa M; Gabius HJ Eur J Nucl Med; 1990; 16(11):781-6. PubMed ID: 2209646 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and tumor localization of (111)in-labeled HuCC49DeltaC(H)2 in BALB/c mice and athymic murine colon carcinoma xenograft. Chinn PC; Morena RA; Santoro DA; Kazules T; Kashmiri SV; Schlom J; Hanna N; Braslawsky G Cancer Biother Radiopharm; 2006 Apr; 21(2):106-16. PubMed ID: 16706631 [TBL] [Abstract][Full Text] [Related]
11. Kinetic and catabolic considerations of monoclonal antibody targeting in erythroleukemic mice. Scheinberg DA; Strand M Cancer Res; 1983 Jan; 43(1):265-72. PubMed ID: 6571707 [TBL] [Abstract][Full Text] [Related]
12. Diverse characteristics of 111In labelled anti-CEA monoclonal antibodies for tumour immunoscintigraphy: radiolabelling, biodistribution and imaging studies in mice with human tumour xenografts. Pimm MV; Perkins AC; Baldwin RW Eur J Nucl Med; 1987; 12(10):515-21. PubMed ID: 3569340 [TBL] [Abstract][Full Text] [Related]
13. Biodistribution and dosimetry following infusion of antibodies labeled with large amounts of 131I. Badger CC; Davis J; Nourigat C; Wu ZM; Hui TE; Fisher DR; Shulman H; Appelbaum FR; Eary JF; Krohn KA Cancer Res; 1991 Nov; 51(21):5921-8. PubMed ID: 1682038 [TBL] [Abstract][Full Text] [Related]
14. Clearance of yttrium-90-labelled anti-tumour antibodies with antibodies raised against the 12N4 DOTA macrocycle. Casey JL; King DJ; Pedley RB; Boden JA; Boden R; Chaplin LC; Dorning M; Begent RH Br J Cancer; 1998 Nov; 78(10):1307-12. PubMed ID: 9823971 [TBL] [Abstract][Full Text] [Related]
16. BLEDTA: tumor localization by a bleomycin analogue containing a metal-chelating group. DeRiemer LH; Meares CF; Goodwin DA; Diamanti CI J Med Chem; 1979 Sep; 22(9):1019-23. PubMed ID: 90724 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics in patients of an anti-carcinoembryonic antigen antibody radiolabeled with indium-111 using a novel diethylenetriamine pentaacetic acid chelator. Hnatowich DJ; Rusckowski M; Brill AB; Siebecker DA; Misra H; Mardirossian G; Bushe H; Rescigno A; Stevens S; Johnson DK Cancer Res; 1990 Nov; 50(22):7272-8. PubMed ID: 2224858 [TBL] [Abstract][Full Text] [Related]
18. Galactose-conjugated antibodies in cancer therapy: properties and principles of action. Ong GL; Ettenson D; Sharkey RM; Marks A; Baumal R; Goldenberg DM; Mattes MJ Cancer Res; 1991 Mar; 51(6):1619-26. PubMed ID: 1998953 [TBL] [Abstract][Full Text] [Related]
19. Biodistribution and kinetics of radiolabeled proteins in rats with focal infection. Oyen WJ; Claessens RA; van der Meer JW; Corstens FH J Nucl Med; 1992 Mar; 33(3):388-94. PubMed ID: 1740708 [TBL] [Abstract][Full Text] [Related]
20. Targeting strategies for cancer radiotherapy. Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]